520880 港股通创新药ETF华宝
已收盘 04-28 14:59:58
资讯
新帖
简况
什么情况?港股通创新药突遭重挫,龙头领跌12%!520880放量跌4.51%连失多根均线,加仓还是离场?
新浪基金 · 04-24
什么情况?港股通创新药突遭重挫,龙头领跌12%!520880放量跌4.51%连失多根均线,加仓还是离场?
【ETF动向】4月23日港股通创新药ETF华宝基金跌4.51%,份额增加7200万份
证券之星 · 04-24
【ETF动向】4月23日港股通创新药ETF华宝基金跌4.51%,份额增加7200万份
礼来70亿美元大动作!港股医药再迎布局窗口?华宝基金港股通创新药ETF、港股通医疗ETF宽幅溢价!
新浪基金 · 04-21
礼来70亿美元大动作!港股医药再迎布局窗口?华宝基金港股通创新药ETF、港股通医疗ETF宽幅溢价!
国办9号文正式发布,利好医药创新!华宝基金港股通创新药ETF(520880)、港股通医疗ETF携手涨逾2.5%!
新浪基金 · 04-15
国办9号文正式发布,利好医药创新!华宝基金港股通创新药ETF(520880)、港股通医疗ETF携手涨逾2.5%!
【ETF动向】4月1日港股通创新药ETF华宝基金涨6.99%,份额减少8000万份
证券之星 · 04-02
【ETF动向】4月1日港股通创新药ETF华宝基金涨6.99%,份额减少8000万份
强业绩提振,港股通创新药逆市续涨,520880收复20日线!乐普生物-B绩后狂飙14%
新浪基金 · 03-26
强业绩提振,港股通创新药逆市续涨,520880收复20日线!乐普生物-B绩后狂飙14%
景顺长城中证港股通创新药ETF联接A基金经理变动:张晓南不再担任该基金基金经理
证券之星 · 03-20
景顺长城中证港股通创新药ETF联接A基金经理变动:张晓南不再担任该基金基金经理
医药板块周线回调,关注港股通创新药ETF易方达(159316)、创新药ETF易方达(516080)等产品布局机会
证券之星 · 03-13
医药板块周线回调,关注港股通创新药ETF易方达(159316)、创新药ETF易方达(516080)等产品布局机会
【ETF动向】3月10日汇添富国证港股通创新药ETF基金涨4.31%,份额减少3.39亿份
证券之星 · 03-11
【ETF动向】3月10日汇添富国证港股通创新药ETF基金涨4.31%,份额减少3.39亿份
【ETF动向】3月9日汇添富国证港股通创新药ETF基金跌2.37%,份额增加1.71亿份
证券之星 · 03-10
【ETF动向】3月9日汇添富国证港股通创新药ETF基金跌2.37%,份额增加1.71亿份
反弹来了!港股通创新药ETF(520880)大涨超3%!中国生物制药新签大单,创移植赛道最大规模交易
新浪基金 · 03-05
反弹来了!港股通创新药ETF(520880)大涨超3%!中国生物制药新签大单,创移植赛道最大规模交易
【ETF动向】3月3日银华国证港股通创新药ETF基金跌3.59%,份额增加1.44亿份
证券之星 · 03-04
【ETF动向】3月3日银华国证港股通创新药ETF基金跌3.59%,份额增加1.44亿份
关键节点!港股通创新药ETF(520880)、港股通医疗ETF(159137)盘中齐探历史新低!场内溢价不止
新浪基金 · 03-03
关键节点!港股通创新药ETF(520880)、港股通医疗ETF(159137)盘中齐探历史新低!场内溢价不止
什么情况?百济神州绩前挫逾6%!港股通创新药ETF(520880)、港股通医疗ETF(159137)跌近3%
新浪基金 · 02-26
什么情况?百济神州绩前挫逾6%!港股通创新药ETF(520880)、港股通医疗ETF(159137)跌近3%
【ETF动向】2月10日汇添富国证港股通创新药ETF基金涨3.27%,份额增加1.28亿份
证券之星 · 02-11
【ETF动向】2月10日汇添富国证港股通创新药ETF基金涨3.27%,份额增加1.28亿份
震撼88.5亿美金!天价创新药BD点火,520880摸高2.75%,港股通医疗ETF(159137)五连阳!机构提示低位机遇
新浪基金 · 02-09
震撼88.5亿美金!天价创新药BD点火,520880摸高2.75%,港股通医疗ETF(159137)五连阳!机构提示低位机遇
信达生物与礼来达成重磅合作,港股通创新药ETF易方达涨1.77%
财闻 · 02-09
信达生物与礼来达成重磅合作,港股通创新药ETF易方达涨1.77%
签下185亿美元超级大单,石药为何反遭抛售?“聪明钱”悄然借道港股通创新药ETF(520880)埋伏
新浪基金 · 02-01
签下185亿美元超级大单,石药为何反遭抛售?“聪明钱”悄然借道港股通创新药ETF(520880)埋伏
新修订《药品管理法实施条例》发布,港股通创新药ETF(520880)放量反弹,亿元级资金提前进场
新浪基金 · 01-28
新修订《药品管理法实施条例》发布,港股通创新药ETF(520880)放量反弹,亿元级资金提前进场
创新药出海BD仍然火爆!港股通创新药ETF(520880)跌1.5%延续高溢价,最新单周吸金2.36亿元
新浪基金 · 01-26
创新药出海BD仍然火爆!港股通创新药ETF(520880)跌1.5%延续高溢价,最新单周吸金2.36亿元
加载更多
公司概况
公司名称:
--
所属市场:
上市日期:
--
主营业务:
发行价格:
--
{"stockData":{"symbol":"520880","market":"SH","secType":"STK","nameCN":"港股通创新药ETF华宝","latestPrice":0.496,"timestamp":1777359598000,"preClose":0.505,"halted":0,"volume":784794400,"delay":0,"changeRate":-0.0178,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":-0.009,"latestTime":"04-28 14:59:58","open":0.505,"high":0.516,"low":0.495,"amount":397000000,"amplitude":0.0416,"askPrice":0.497,"askSize":53377,"bidPrice":0.496,"bidSize":30147,"shortable":0,"etf":1,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777426200000},"marketStatusCode":5,"adr":0,"adjPreClose":0.505,"symbolType":"fund","openAndCloseTimeList":[[1777339800000,1777347000000],[1777352400000,1777359600000]],"highLimit":0.556,"lowLimit":0.455,"ibTradeSell":false,"ibTradeBuySell":false,"isCdr":false,"pbRate":0,"committee":-0.241399,"marketValue":0,"turnoverRate":0,"status":1,"floatMarketCap":0},"requestUrl":"/m/hq/s/520880","defaultTab":"news","newsList":[{"id":"2629707860","title":"什么情况?港股通创新药突遭重挫,龙头领跌12%!520880放量跌4.51%连失多根均线,加仓还是离场?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629707860","media":"新浪基金","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629707860?lang=zh_cn&edition=full","pubTime":"2026-04-24 09:18","pubTimestamp":1776993480,"startTime":"0","endTime":"0","summary":"4月23日,港股继续调整,恒指放量连阴失守26000点。港股通创新药突遭急跌,100%创新药研发标的——港股通创新药ETF华宝收跌4.51%五连阴,失守10日、20日及半年线等3根均线。 值得关注的是,520880全天宽幅溢价,且交投尤为活跃,全天成交3.8亿元,较上日激增逾95%。 权重龙头多股重挫为主要拖累,前十成份股中仅石药集团逆市收涨1.71%,康方生物领跌12.66%,三生制药跌9.63%,信达生物、科伦博泰生物跌近6%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-04-24/doc-inhvqfhn3227784.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06978","159992","BK1161","VXUS","BK1574","520880","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629861949","title":"【ETF动向】4月23日港股通创新药ETF华宝基金跌4.51%,份额增加7200万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2629861949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629861949?lang=zh_cn&edition=full","pubTime":"2026-04-24 06:32","pubTimestamp":1776983534,"startTime":"0","endTime":"0","summary":"证券之星消息,4月23日,港股通创新药ETF华宝基金(520880)跌4.51%,成交额3.8亿元。当日份额增加了7200万份,最新份额为42.42亿份,近20个交易日份额减少4.42亿份。当日资金净流出7179.81万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为21.57亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-4.97%,近一个月超额回报为-0.22%,管理人为华宝基金公司,基金经理为丰晨成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400020430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629706271","title":"礼来70亿美元大动作!港股医药再迎布局窗口?华宝基金港股通创新药ETF、港股通医疗ETF宽幅溢价!","url":"https://stock-news.laohu8.com/highlight/detail?id=2629706271","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629706271?lang=zh_cn&edition=full","pubTime":"2026-04-21 11:14","pubTimestamp":1776741240,"startTime":"0","endTime":"0","summary":"4月21日早盘,港股医药资产全线调整,100%创新药研发标的——港股通创新药ETF华宝、港股医疗核心资产——港股通医疗ETF华宝双双跌逾1%,不过场内均呈现宽幅溢价,显示买盘资金活跃。 个股方面,港股通创新药权重龙头普遍飘绿,康方生物跌逾2%,信达生物、中国生物制药、翰森制药齐跌逾1%。港股医疗权重股亦普跌,药明康德、晶泰控股跌2%。 消息面,隔夜,礼来宣布以最高70亿美元的总对价收购Kelonia Therapeutics,旨在获取其核心的体内CAR-T平台。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-04-21/doc-inhvfqcm0239457.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BJT1NW94.SGD","LU0133085943.USD","LU0471298777.SGD","LU0820561818.USD","BK4581","LU2552382132.HKD","IE00B1XK9C88.USD","LU0198837287.USD","LU2750360641.GBP","IE00B4JS1V06.HKD","SG9999014906.USD","LU1551013425.SGD","LU2471134523.USD","LU2237438978.USD","LU1712237335.SGD","LU0683600562.USD","LU1232071149.USD","159137","LU0316494557.USD","LU0823434740.USD","LU1323610961.USD","LU2237443622.USD","LU2357305700.SGD","LU2750360997.AUD","BK4516","LU1868837136.USD","IE0004445239.USD","LU1629891620.HKD","LU0079474960.USD","LU2168564495.EUR","LU1267930730.SGD","LU2023250504.SGD","LU2491049909.HKD","LU0964807845.USD","LU2896262040.SGD","LU0882574139.USD","SG9999015952.SGD","520880","IE00BFSS8Q28.SGD","IE00BJJMRZ35.SGD","LU1023059063.AUD","IE00BFSS7M15.SGD","LU2211815571.USD","LU1366192091.USD","LU0094547139.USD","BK4534","LU1988902786.USD","LU2602419157.SGD","LU2112291526.USD","GB00BDT5M118.USD","LU0109391861.USD","LU0256863811.USD","LU2023251221.USD","LU2237443549.SGD","LU2468319806.SGD","LU1868836757.USD","LU2360106947.USD","SG9999014880.SGD","LU0354030511.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU0820561909.HKD","SG9999001176.SGD","LU2089284900.SGD","LU0234572021.USD","LU0672654240.SGD","LU1868836914.USD","LU2237443465.HKD","LU2552382215.SGD","LU0158827781.USD","LU0096364046.USD","LU2746668461.USD","SG9999014914.USD","SGXZ51526630.SGD","LU2106854487.HKD","LU1720051017.SGD","SGXZ31699556.SGD","IE00BKPKM429.USD","LU0058720904.USD","LU2089283258.USD","LU1280957306.USD","IE0005OL40V9.USD","LU1983299246.USD","LU2552382058.USD","SGXZ57979304.SGD","LU1093756168.USD","LU2462157665.USD","LU2213496289.HKD","IE00B775H168.HKD","IE00B1BXHZ80.USD","LU0640476718.USD","IE00BK4W5M84.HKD","LLYX","SG9999001176.USD","LU0385154629.USD","LU2361044949.HKD","LU0823434583.USD","SG9999018865.SGD","SGXZ81514606.USD","IE0001KFT4U8.USD","LU1974910355.USD","LU1127390331.HKD","IE00BK4W5L77.USD","LU0320765059.SGD","LU0708995401.HKD","LU1064131342.USD","LU2756315318.SGD","LU2471134952.CNY","IE00BN29S564.USD","LU0114720955.EUR","IE00B7KXQ091.USD","LU0820562030.AUD","LU2756315664.SGD","LU2168564065.EUR","LU1989771016.USD","LU0417517546.SGD","LU2028103732.USD","LU2168564149.EUR","LU2063271972.USD","IE00BJLML261.HKD","LU0210536198.USD","IE0004445015.USD","LU2324357040.USD","LU2461242641.AUD","SG9999015986.USD","LU2491050154.USD","IE00BFTCPJ56.SGD","LU2087625088.SGD","LU0238689110.USD","IE00BWXC8680.SGD","LU0006306889.USD","LU0456855351.SGD","LU1061106388.HKD","LU2023250330.USD","SG9999018857.SGD","ELIL","IE00BKDWB100.SGD","IE00BJJMRX11.SGD","LU1917777945.USD","LU2361045086.USD","LU2271345857.HKD","LU1623119135.USD","LU2471134796.USD","LU2417539215.USD","LU1551013342.USD","LU1868836591.USD","LU2471134879.HKD","LU0882574055.USD","LU1035775433.USD","LLII","LU2361044865.SGD","LU0106261372.USD","SG9999013999.USD","LU2168563687.JPY","LU0061475181.USD","SG9999015945.SGD","LU2168564222.USD","LU1814569148.SGD","LU2237443978.SGD","BK4588","LU0787776722.HKD","LU2236285917.USD","LU0466842654.USD","LU2265009873.SGD","SG9999014898.SGD","LU2491050071.SGD","LU1093756325.SGD","LU0097036916.USD","LU2746668974.SGD","LU0323591593.USD","LU1291159041.SGD","LU1069344957.HKD","LLYZ","LU2108987350.USD","ELIS","BK4007","LU0786609619.USD","LU0889565916.HKD","LU0353189763.USD","IE0002141913.USD","BK4585","LU0109394709.USD","LU1057294990.SGD","LU0943347566.SGD","LU2089984988.USD","LU2237443895.HKD","LU2264538146.SGD","LU0320765992.SGD","LU0689472784.USD","LU0289739699.SGD","LU0225283273.USD","LU0122379950.USD","LU0203201768.USD","LU0353189680.USD","LU0266013472.USD","BK4533","LU0471298694.HKD","LU1548497426.USD","LU1804176565.USD","SG9999017495.SGD","LU0203202063.USD","LU1720051108.HKD","IE0009355771.USD","LU2111349929.HKD","LU2237443382.USD","LU1868837300.USD","LU0158827948.USD","SGXZ99366536.SGD","IE00B4R5TH58.HKD","LU0823416689.USD","LU2456880835.USD","BK4599","LU1145028129.USD","LU0256863902.USD","SG9999015978.USD","IE00B2B36J28.USD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627471345","title":"国办9号文正式发布,利好医药创新!华宝基金港股通创新药ETF(520880)、港股通医疗ETF携手涨逾2.5%!","url":"https://stock-news.laohu8.com/highlight/detail?id=2627471345","media":"新浪基金","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627471345?lang=zh_cn&edition=full","pubTime":"2026-04-15 10:11","pubTimestamp":1776219060,"startTime":"0","endTime":"0","summary":"重磅政策利好来袭,4月15日早盘,港股医药强劲反弹!100%创新药研发标的——港股通创新药ETF华宝一度冲上3%,现涨2.5%,权重龙头集体拉涨,信达生物涨超4%,百济神州、中国生物制药涨超3%。 港股医疗同步活跃,场内热门港股通医疗ETF华宝放量涨2.59%冲击连阳,权重股晶泰控股劲涨6%,京东健康涨4%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"91f24949debf4aed7e22faec526c7ddd","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-04-15/doc-inhupvfa4217667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["520880","09939","159938","BK1515","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624547692","title":"【ETF动向】4月1日港股通创新药ETF华宝基金涨6.99%,份额减少8000万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2624547692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624547692?lang=zh_cn&edition=full","pubTime":"2026-04-02 06:32","pubTimestamp":1775082731,"startTime":"0","endTime":"0","summary":"证券之星消息,4月1日,港股通创新药ETF华宝基金(520880)涨6.99%,成交额10.84亿元。当日份额减少了8000万份,最新份额为45.14亿份,近20个交易日份额减少2.62亿份。当日资金净流入1.25亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为24.28亿元。港股通创新药ETF华宝基金跟踪标的为恒生港股通创新药精选指数,成立(2025-06-27)以来超额回报为-5.19%,近一个月超额回报为-0.9%,管理人为华宝基金公司,基金经理为丰晨成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200003163.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622882066","title":"强业绩提振,港股通创新药逆市续涨,520880收复20日线!乐普生物-B绩后狂飙14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622882066","media":"新浪基金","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622882066?lang=zh_cn&edition=full","pubTime":"2026-03-26 11:03","pubTimestamp":1774494180,"startTime":"0","endTime":"0","summary":"3月26日,港股通医药再度逆市表现,100%创新药研发标的——港股通创新药ETF华宝、港股医疗核心资产——港股通医疗ETF华宝双双高开,一度携手涨超1%!520880量价齐升,盘中收复20日线,实时成交超2亿元。 创新药多股领跑,乐普生物-B盘中飙升逾14%站上半年线,领涨所有港股通标的。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-03-26/doc-inhshtfa2929921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","02157","520880","BK4588","06978","159992","BK1574","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620820304","title":"景顺长城中证港股通创新药ETF联接A基金经理变动:张晓南不再担任该基金基金经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2620820304","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620820304?lang=zh_cn&edition=full","pubTime":"2026-03-20 09:31","pubTimestamp":1773970281,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年3月20日,景顺长城中证港股通创新药ETF联接(023597)发布公告,张晓南不再担任该基金基金经理,离任日期为2026年3月20日,变更后景顺长城中证港股通创新药ETF联接(023597)的基金经理为金璜。截止2026年3月19日,景顺长城中证港股通创新药ETF联接净值为1.3429,较上一日下跌2.67%,近一年上涨33.48%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000007824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619719965","title":"医药板块周线回调,关注港股通创新药ETF易方达(159316)、创新药ETF易方达(516080)等产品布局机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2619719965","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619719965?lang=zh_cn&edition=full","pubTime":"2026-03-13 18:55","pubTimestamp":1773399353,"startTime":"0","endTime":"0","summary":"本周,中证创新药产业指数下跌0.8%,沪深300医药卫生指数下跌1.0%,中证生物科技主题指数下跌1.1%,恒生港股通创新药指数下跌3.0%,中证港股通医药卫生综合指数下跌3.4%。Wind数据显示,截至昨日,港股通创新药ETF易方达(159316,联接基金A/C:024328/024329)和创新药ETF易方达(516080,联接基金A/C:019666/019667)本周分别获3600万元和2100万元资金净流入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/SS2026031300033395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","159938","09939","BK1515","516080","BK1161","520880","159316"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618743960","title":"【ETF动向】3月10日汇添富国证港股通创新药ETF基金涨4.31%,份额减少3.39亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2618743960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618743960?lang=zh_cn&edition=full","pubTime":"2026-03-11 08:02","pubTimestamp":1773187343,"startTime":"0","endTime":"0","summary":"证券之星消息,3月10日,汇添富国证港股通创新药ETF基金(159570)涨4.31%,成交额26.83亿元。当日份额减少了3.39亿份,最新份额为150.34亿份,近20个交易日份额减少2.97亿份。当日资金净流入2.35亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为233.17亿元。汇添富国证港股通创新药ETF基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-11.72%,近一个月超额回报为-3.13%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100006189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618008603","title":"【ETF动向】3月9日汇添富国证港股通创新药ETF基金跌2.37%,份额增加1.71亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2618008603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618008603?lang=zh_cn&edition=full","pubTime":"2026-03-10 08:02","pubTimestamp":1773100938,"startTime":"0","endTime":"0","summary":"证券之星消息,3月9日,汇添富国证港股通创新药ETF基金(159570)跌2.37%,成交额27.28亿元。当日份额增加了1.71亿份,最新份额为153.73亿份,近20个交易日份额增加5400万份。当日资金净流出6855.77万元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为230.82亿元。汇添富国证港股通创新药ETF基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-13.04%,近一个月超额回报为-4.12%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000004129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617596171","title":"反弹来了!港股通创新药ETF(520880)大涨超3%!中国生物制药新签大单,创移植赛道最大规模交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2617596171","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617596171?lang=zh_cn&edition=full","pubTime":"2026-03-05 10:14","pubTimestamp":1772676840,"startTime":"0","endTime":"0","summary":"创新药龙头普涨,100%创新药研发标的——港股通创新药ETF高开高走,现涨超3%。昨日,520880录得五连跌,场内价格创下历史新低,不过资金逆行增仓,连续5日低吸合计逾1.35亿元。 权重股中国生物制药大涨超5%,该股昨日公告称,与赛诺菲就罗伐昔替尼订立独家授权协议,获1.35亿美元首付款、最高13.95亿美元里程碑付款,并享有基于年度净销售额的最高双位数阶梯式特许权使用费。这是中国药企在移植领域创下的最大规模对外授权交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-03-05/doc-inhpwzrx3294783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BZ08YT58.USD","BK1589","HK0000165453.HKD","BK1515","IE00BZ08YR35.GBP","BK1521","IE00BZ08YS42.EUR","520880","01177","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616911303","title":"【ETF动向】3月3日银华国证港股通创新药ETF基金跌3.59%,份额增加1.44亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2616911303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616911303?lang=zh_cn&edition=full","pubTime":"2026-03-04 08:02","pubTimestamp":1772582541,"startTime":"0","endTime":"0","summary":"证券之星消息,3月3日,银华国证港股通创新药ETF基金(159567)跌3.59%,成交额10.34亿元。当日份额增加了1.44亿份,最新份额为102.75亿份,近20个交易日份额减少6200万份。当日资金净流出1.8亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为72.25亿元。银华国证港股通创新药ETF基金跟踪标的为国证港股通创新药指数,成立(2024-01-03)以来超额回报为-39.63%,近一个月超额回报为-2.85%,管理人为银华基金公司,基金经理为马君。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400007213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616743391","title":"关键节点!港股通创新药ETF(520880)、港股通医疗ETF(159137)盘中齐探历史新低!场内溢价不止","url":"https://stock-news.laohu8.com/highlight/detail?id=2616743391","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616743391?lang=zh_cn&edition=full","pubTime":"2026-03-03 11:05","pubTimestamp":1772507100,"startTime":"0","endTime":"0","summary":"3月3日早盘,港股医药延续调整,盘中探底回升。 创新药龙头齐跌,石药集团跌逾2%,百济神州、信达生物跌逾1%,港股通创新药ETF盘中下探逾2%续创上市以来新低,不过场内持续溢价交易,显示低吸资金活跃,此前3日合计7755万元逢跌净申购。 港股医疗板块同步调整,药明生物、京东健康跌逾1%,晶泰控股、平安好医生逆市涨逾2%,港股通医疗ETF华宝盘中亦探上市以来新低,现跌1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-03-03/doc-inhpspmr0870861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["520880","159137","520510"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614009264","title":"什么情况?百济神州绩前挫逾6%!港股通创新药ETF(520880)、港股通医疗ETF(159137)跌近3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009264","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614009264?lang=zh_cn&edition=full","pubTime":"2026-02-26 15:01","pubTimestamp":1772089260,"startTime":"0","endTime":"0","summary":"2月26日午后,港股医药股加速走低,创新药产业链跌幅靠前,港股通创新药ETF、港股通医疗ETF华宝双双跌逾2%,场内溢价同步走高,显示“抄底”资金有所行动。 个股方面,权重龙头百济神州跌逾6%居首,据悉,该公司将于今日披露2025年财报。作为创新药领域龙头企业,百济神州为港股通创新药ETF 、港股通医疗ETF华宝持仓股,权重占比分别为11.27%、2.13%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7aeeed2b7873496584fe7f3c4e94617c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-02-26/doc-inhpcqkn4412142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","BK1583","LU1251922891.USD","BK1500","06160","LU0588546209.SGD","520880","LU1719994722.HKD","BK0239","LU1303224171.USD","BK1161","LU1969619763.USD","ONC","BK4139","BK4526","LU1770034418.SGD","688235","LU2328871848.SGD","159137","520510","BK1588","BK4588","LU0307460666.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610467060","title":"【ETF动向】2月10日汇添富国证港股通创新药ETF基金涨3.27%,份额增加1.28亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2610467060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610467060?lang=zh_cn&edition=full","pubTime":"2026-02-11 08:02","pubTimestamp":1770768132,"startTime":"0","endTime":"0","summary":"证券之星消息,2月10日,汇添富国证港股通创新药ETF基金(159570)涨3.27%,成交额26.27亿元。当日份额增加了1.28亿份,最新份额为155.55亿份,近20个交易日份额增加5.22亿份。当日资金净流入8.64亿元(资金流向是当日计算的资产净值和上一交易日计算的资产净值相减得出的),最新资产净值计算值为258.69亿元。汇添富国证港股通创新药ETF基金跟踪标的为国证港股通创新药指数,成立(2023-12-28)以来超额回报为-38.06%,近一个月超额回报为-0.38%,管理人为汇添富基金公司,基金经理为乐无穹。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100004724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610321436","title":"震撼88.5亿美金!天价创新药BD点火,520880摸高2.75%,港股通医疗ETF(159137)五连阳!机构提示低位机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2610321436","media":"新浪基金","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610321436?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:36","pubTimestamp":1770636960,"startTime":"0","endTime":"0","summary":"2月9日,港股市场全面反弹,港股医药板块延续修复行情。 信达生物拿下88.5亿美元BD大单,无意外全天领涨,最高涨至8.55%,收涨7.42%,龙头股大受提振,百济神州涨超3%,石药集团、中国生物制药、三生制药集体跟涨。 100%创新药研发标的——港股通创新药ETF高开后上探2.75%,收涨1.77%成功连阳,一并站上10日均线,全天成交3.81亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-02-09/doc-inhmfqca5267862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","BK1161","520880","06978","520510","BK1574","159137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610558688","title":"信达生物与礼来达成重磅合作,港股通创新药ETF易方达涨1.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610558688","media":"财闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610558688?lang=zh_cn&edition=full","pubTime":"2026-02-09 10:44","pubTimestamp":1770605040,"startTime":"0","endTime":"0","summary":"截止2月9日10点23分,上证指数涨1.26%,深证成指涨1.69%,创业板指涨2.08%。光伏设备、影视院线、HJT电池等板块涨幅居前。ETF方面,港股通创新药ETF易方达(159316)涨1.77%,成分股康诺亚- ...","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"34f23f16691bc3dd0945b028f8bb922f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://fund.10jqka.com.cn/20260209/c674649029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608405007","title":"签下185亿美元超级大单,石药为何反遭抛售?“聪明钱”悄然借道港股通创新药ETF(520880)埋伏","url":"https://stock-news.laohu8.com/highlight/detail?id=2608405007","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608405007?lang=zh_cn&edition=full","pubTime":"2026-02-01 19:37","pubTimestamp":1769945820,"startTime":"0","endTime":"0","summary":"中国创新药出海BD再获里程碑式突破! 1月30日,石药集团宣布已与全球生物制药领导者阿斯利康签订战略研发合作与授权协议,以利用集团专有的缓释给药技术平台及多肽药物AI发现平台,开发创新长效多肽药物。若后续所有研发及销售里程碑均达成,石药集团方面有权获得总计高达185亿美元的款项。其12亿美元的预付款,仅次于此前三生制药与辉瑞就PD-1/VEGF达成的数额。此前10日,520880累获逾2.74亿元资金净申购。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-02-01/doc-inhkihyz4934390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BZ08YT58.USD","LU1008478684.HKD","LU1813983027.USD","LU1226287875.USD","IE00B543WZ88.USD","LU1951186391.HKD","520880","LU1960683339.HKD","LU0314109678.HKD","LU1328277881.USD","IE00B5MMRT66.SGD","LU0067412154.USD","LU1152091168.USD","LU0880133367.SGD","BK1515","LU1152091754.HKD","LU0072913022.USD","BK1521","01093","IE0008368742.USD","LU0140636845.USD","HK0000165453.HKD","IE00BZ08YS42.EUR","IE0008369823.USD","BK1191","IE00B031HY20.USD","LU1226287529.USD","LU1226287792.SGD","LU1807302812.USD","SG9999004220.SGD","LU0326950275.SGD","LU1993786604.SGD","LU1226288253.USD","LU0501845795.SGD","LU0315179316.USD","IE00BZ08YR35.GBP","LU1226288170.HKD","LU2039709279.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606763233","title":"新修订《药品管理法实施条例》发布,港股通创新药ETF(520880)放量反弹,亿元级资金提前进场","url":"https://stock-news.laohu8.com/highlight/detail?id=2606763233","media":"新浪基金","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606763233?lang=zh_cn&edition=full","pubTime":"2026-01-28 10:52","pubTimestamp":1769568720,"startTime":"0","endTime":"0","summary":"1月28日,港股通创新药板块回暖,龙头股石药集团涨超3%,百济神州、中国生物制药、信达生物集体上涨。 100%创新药研发标的——港股通创新药ETF一度涨逾1.5%,成交快速突破2亿元。近期资金面持续升温,截至昨日,520880近5日吸金1.9亿元,份额升至46.18亿份,再创历史新高。 消息面,1月27日,新修订《药品管理法实施条例》发布,首次为儿童药、罕见病药设立最长7年市场独占期,并强化网售平台责任。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-01-28/doc-inhivmmh4033981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["520880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606629646","title":"创新药出海BD仍然火爆!港股通创新药ETF(520880)跌1.5%延续高溢价,最新单周吸金2.36亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606629646","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606629646?lang=zh_cn&edition=full","pubTime":"2026-01-26 13:42","pubTimestamp":1769406120,"startTime":"0","endTime":"0","summary":"1月26日,港股再陷调整,创新药板块再度走低,港股通创新药ETF跌1.5%,场内延续高溢价,显示买盘态度积极。上周,520880累跌3.2%,单周获超2.36亿元资金逢跌吸筹。 成份股方面,龙头股呈普跌态势,石药集团跌3%,康方生物跌近4%,中国生物制药、信达生物跌逾2%。 资金频频逆市增仓,产业方面,年初多个创新药BD交易落地,中国创新药出海的趋势向好。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-01-26/doc-inhircpe6485511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159992","520880","06978","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777395922783,"stockEarnings":[{"period":"1week","weight":-0.0746},{"period":"1month","weight":-0.004},{"period":"3month","weight":-0.0677},{"period":"6month","weight":-0.0764},{"period":"ytd","weight":-0.004}],"compareEarnings":[{"period":"1week","weight":-0.0016},{"period":"1month","weight":0.0421},{"period":"3month","weight":-0.0175},{"period":"6month","weight":0.023},{"period":"1year","weight":0.2403},{"period":"ytd","weight":0.0277}],"compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"港股通创新药ETF华宝(520880)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供港股通创新药ETF华宝(520880)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"港股通创新药ETF华宝,520880,港股通创新药ETF华宝股票,港股通创新药ETF华宝股票老虎,港股通创新药ETF华宝股票老虎国际,港股通创新药ETF华宝行情,港股通创新药ETF华宝股票行情,港股通创新药ETF华宝股价,港股通创新药ETF华宝股市,港股通创新药ETF华宝股票价格,港股通创新药ETF华宝股票交易,港股通创新药ETF华宝股票购买,港股通创新药ETF华宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"港股通创新药ETF华宝(520880)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供港股通创新药ETF华宝(520880)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}